{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:10:05Z","timestamp":1761855005444,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.dld.2018.09.010","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T00:24:26Z","timestamp":1537575866000},"page":"434-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy"],"prefix":"10.1016","volume":"51","author":[{"given":"Tommaso","family":"Stroffolini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelista","family":"Sagnelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6413-7810","authenticated-orcid":false,"given":"Caterina","family":"Sagnelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonina","family":"Smedile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9059-8311","authenticated-orcid":false,"given":"Filomena","family":"Morisco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Andriulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0406-8494","authenticated-orcid":false,"given":"Piero Luigi","family":"Almasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2018.09.010_bib0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hep.29109","article-title":"Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: a systematic review and meta-analysis","volume":"66","author":"Chen","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2018.09.010_bib0010","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jhep.2017.08.017","article-title":"HBV recurrence after HCV clearance on DAAs: sometimes they come back","volume":"67","author":"Calvaruso","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2018.09.010_bib0015","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/ajg.2017.397","article-title":"Isolated anti-HBc: the relevance of hepatitis B core antibody\u2014a review of new issues","volume":"112","author":"Wu","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.09.010_bib0020","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/infdis\/163.2.400","article-title":"Hepatitis C virus infection in chronic hepatitis B virus carriers","volume":"163","author":"Fattovich","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.dld.2018.09.010_bib0025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0168-8278(94)80094-4","article-title":"Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients","volume":"21","author":"Ohkawa","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2018.09.010_bib0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0168-8278(05)80389-7","article-title":"Coinfection of hepatitis C virus in patients with chronic hepatitis B infection","volume":"21","author":"Sato","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2018.09.010_bib0035","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0168-8278(03)00470-7","article-title":"Epidemiological and clinical burden of chronic hepatitis B virus\/hepatitis C virus infection. A multicenter Italian study","volume":"39","author":"Gaeta","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2018.09.010_bib0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"The Polaris Observatory HCV Collaborators","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.09.010_bib0045","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/hep.23461","article-title":"Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: prevalence, racial\/ethnic differences, and viral interactions","volume":"51","author":"Bini","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2018.09.010_bib0050","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/jmv.20313","article-title":"The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases","volume":"75","author":"Sagnelli","year":"2005","journal-title":"J Med Virol"},{"key":"10.1016\/j.dld.2018.09.010_bib0055","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.dld.2016.05.014","article-title":"Epidemiological and clinical scenario of chronic liver diseases in Italy: data from a multicenter nationwide survey","volume":"48","author":"Sagnelli","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2018.09.010_bib0060","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0168-8278(97)80140-7","article-title":"What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy","volume":"27","author":"Gaiani","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2018.09.010_bib0065","first-page":"421","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference","volume":"35","author":"Bruix","year":"2001","journal-title":"European Association for the Study of the Liver J Hepatol"},{"key":"10.1016\/j.dld.2018.09.010_bib0070","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review","volume":"166","author":"Falade-Nwulia","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2018.09.010_bib0075","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/jhep.2000.19288","article-title":"Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis","volume":"32","author":"Sagnelli","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2018.09.010_bib0080","doi-asserted-by":"crossref","first-page":"e0139015","DOI":"10.1371\/journal.pone.0139015","article-title":"Replication inhibition of hepatitis B virus and hepatitis C virus in co-infected patients in Chinese population","volume":"10","author":"Yu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2018.09.010_bib0085","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2018.09.010_bib0090","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.dld.2005.02.010","article-title":"The changing pattern of hepatitis B virus infection over the past three decades in Italy","volume":"37","author":"Stroffolini","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2018.09.010_bib0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0168-8278(98)80198-0","article-title":"Characteristics of patients with dual infection by hepatitis B and C viruses","volume":"28","author":"Zarski","year":"1998","journal-title":"J Hepatol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818309800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818309800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T18:47:30Z","timestamp":1752000450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865818309800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1590865818309800"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2018.09.010","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2018.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}